Related Experiment Video
Updated: Aug 21, 2026

Analytical Techniques for Assaying Nitric Oxide Bioactivity
Published on: June 18, 2012
A novel mechanism of action of tetracyclines: effects on nitric oxide synthases
A R Amin1, M G Attur, G D Thakker
1Department of Rheumatology, Hospital for Joint Diseases, New York, NY 10003, USA.
Abstract:
Tetracyclines have recently been shown to have "chondroprotective" effects in inflammatory arthritides in animal models. Since nitric oxide (NO) is spontaneously released from human cartilage affected by osteoarthritis (OA) or rheumatoid arthritis in quantities sufficient to cause cartilage damage, we evaluated the effect of tetracyclines on the expression and function of human OA-affected nitric oxide synthase (OA-NOS) and rodent inducible NOS (iNOS). Among the tetracycline group of compounds, doxycycline > minocycline blocked and reversed both spontaneous and interleukin 1 beta-induced OA-NOS activity in ex vivo conditions. Similarly, minocycline > or = doxycycline inhibited both lipopolysaccharide- and interferon-gamma-stimulated iNOS in RAW 264.7 cells in vitro, as assessed by nitrite accumulation. Although both these enzyme isoforms could be inhibited by doxycycline and minocycline, their susceptibility to each of these drugs was distinct. Unlike acetylating agents or competitive inhibitors of L-arginine that directly inhibit the specific activity of NOS, doxycycline or minocycline has no significant effect on the specific activity of iNOS in cell-free extracts. The mechanism of action of these drugs on murine iNOS expression was found to be, at least in part, at the level of RNA expression and translation of the enzyme, which would account for the decreased iNOS protein and activity of the enzyme. Tetracyclines had no significant effect on the levels of mRNA for beta-actin and glyceraldehyde-3-phosphate dehydrogenase nor on levels of protein of beta-actin and cyclooxygenase 2 expression. These studies indicate that a novel mechanism of action of tetracyclines is to inhibit the expression of NOS. Since the overproduction of NO has been implicated in the pathogenesis of arthritis, as well as other inflammatory diseases, these observations suggest that tetracyclines should be evaluated as potential therapeutic modulators of NO for various pathological conditions.
Insights
Tetracyclines, including doxycycline and minocycline, inhibit nitric oxide synthase (NOS) expression, offering a novel therapeutic approach for inflammatory diseases like arthritis.
Area of Science:
- Biochemistry
- Pharmacology
- Immunology
Background:
- Nitric oxide (NO) contributes to cartilage damage in osteoarthritis (OA) and rheumatoid arthritis.
- Tetracyclines exhibit chondroprotective effects in animal models of inflammatory arthritis.
Purpose of the Study:
- To investigate the impact of tetracyclines on nitric oxide synthase (NOS) expression and function in human OA and rodent models.
- To elucidate the mechanism by which tetracyclines modulate NOS activity.
Main Methods:
- Assessed tetracycline effects on ex vivo human OA-NOS activity and in vitro rodent inducible NOS (iNOS) activity.
- Measured nitrite accumulation to quantify iNOS inhibition.
- Analyzed mRNA and protein expression levels of NOS and control genes.
Main Results:
- Doxycycline and minocycline inhibited both spontaneous and IL-1β-induced OA-NOS activity.
- Minocycline and doxycycline suppressed LPS/IFN-γ-stimulated iNOS activity in RAW 264.7 cells.
- Tetracyclines primarily affected NOS expression at the RNA and translation levels, not enzyme activity directly.
Conclusions:
- Tetracyclines represent a novel class of drugs that inhibit NOS expression.
- This mechanism suggests tetracyclines could be valuable therapeutic agents for inflammatory conditions driven by NO overproduction.
More Related Videos
08:32Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
07:15Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
Published on: July 3, 2025
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Mechanism
Nitrosation of Enols
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...